- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- January 2022
- 60 Pages
Global
From €2732EUR$2,765USD£2,274GBP
€3903EUR$3,950USD£3,248GBP
- Report
- October 2023
- 128 Pages
Europe
From €3952EUR$4,000USD£3,290GBP
- Report
- October 2023
- 133 Pages
Europe
From €3952EUR$4,000USD£3,290GBP
- Report
- October 2023
- 138 Pages
Asia Pacific
From €3952EUR$4,000USD£3,290GBP
- Report
- March 2023
- 119 Pages
Global
From €4446EUR$4,500USD£3,701GBP
- Report
- November 2022
- 120 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- January 2022
- 120 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- November 2023
- 160 Pages
Global
From €2963EUR$2,999USD£2,466GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €5927EUR$5,999USD£4,934GBP
- Report
- May 2023
- 160 Pages
Global
From €5927EUR$5,999USD£4,934GBP
- Report
- May 2023
- 147 Pages
Global
From €5927EUR$5,999USD£4,934GBP
- Report
- March 2023
- 147 Pages
Global
From €5927EUR$5,999USD£4,934GBP
- Report
- August 2023
- 145 Pages
Global
From €3112EUR$3,150USD£2,591GBP
- Clinical Trials
- October 2020
- 192 Pages
Global
From €2470EUR$2,500USD£2,056GBP
- Report
- February 2023
- 32 Pages
Global
From €3947EUR$3,995USD£3,285GBP
- Report
- November 2022
- 100 Pages
Global
From €3903EUR$3,950USD£3,248GBP
- Report
- March 2021
- 133 Pages
Global
From €10864EUR$10,995USD£9,042GBP
- Report
- August 2022
United States
From €1917EUR$1,940USD£1,595GBP
The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more